37
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Rare genetic conditions are frequent risk factors for, or direct causes of, paediatric intensive care unit (PICU) admission. Such conditions are frequently suspected but unidentified at PICU admission. Compassionate and effective care is greatly assisted by definitive diagnostic information. There is therefore a need to provide a rapid genetic diagnosis to inform clinical management.

          To date, whole genome sequencing (WGS) approaches have proved successful in diagnosing a proportion of children with rare diseases, but results may take months to report. Our aim was to develop an end-to-end workflow for the use of rapid WGS for diagnosis in critically ill children in a UK National Health Service (NHS) diagnostic setting.

          Methods

          We sought to establish a multidisciplinary Rapid Paediatric Sequencing team for case selection, trio WGS, rapid bioinformatics sequence analysis and a phased analysis and reporting system to prioritise genes with a high likelihood of being causal.

          Results

          Trio WGS in 24 critically ill children led to a molecular diagnosis in 10 (42%) through the identification of causative genetic variants. In 3 of these 10 individuals (30%), the diagnostic result had an immediate impact on the individual’s clinical management. For the last 14 trios, the shortest time taken to reach a provisional diagnosis was 4 days (median 8.5 days).

          Conclusion

          Rapid WGS can be used to diagnose and inform management of critically ill children within the constraints of an NHS clinical diagnostic setting. We provide a robust workflow that will inform and facilitate the rollout of rapid genome sequencing in the NHS and other healthcare systems globally.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization

          Genetic disorders are a leading cause of morbidity and mortality in infants. Rapid whole-genome sequencing (rWGS) can diagnose genetic disorders in time to change acute medical or surgical management (clinical utility) and improve outcomes in acutely ill infants. We report a retrospective cohort study of acutely ill inpatient infants in a regional children’s hospital from July 2016–March 2017. Forty-two families received rWGS for etiologic diagnosis of genetic disorders. Probands also received standard genetic testing as clinically indicated. Primary end-points were rate of diagnosis, clinical utility, and healthcare utilization. The latter was modelled in six infants by comparing actual utilization with matched historical controls and/or counterfactual utilization had rWGS been performed at different time points. The diagnostic sensitivity of rWGS was 43% (eighteen of 42 infants) and 10% (four of 42 infants) for standard genetic tests (P = .0005). The rate of clinical utility of rWGS (31%, thirteen of 42 infants) was significantly greater than for standard genetic tests (2%, one of 42; P = .0015). Eleven (26%) infants with diagnostic rWGS avoided morbidity, one had a 43% reduction in likelihood of mortality, and one started palliative care. In six of the eleven infants, the changes in management reduced inpatient cost by $800,000–$2,000,000. These findings replicate a prior study of the clinical utility of rWGS in acutely ill inpatient infants, and demonstrate improved outcomes and net healthcare savings. rWGS merits consideration as a first tier test in this setting.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Use of Exome Sequencing for Infants in Intensive Care Units

            While congenital malformations and genetic diseases are a leading cause of early infant death, to our knowledge, the contribution of single-gene disorders in this group is undetermined.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care

              An accurate diagnosis is an integral component of patient care for children with rare genetic disease. Recent advances in sequencing, in particular whole‐exome sequencing (WES), are identifying the genetic basis of disease for 25–40% of patients. The diagnostic rate is probably influenced by when in the diagnostic process WES is used. The Finding Of Rare Disease GEnes (FORGE) Canada project was a nation‐wide effort to identify mutations for childhood‐onset disorders using WES. Most children enrolled in the FORGE project were toward the end of the diagnostic odyssey. The two primary outcomes of FORGE were novel gene discovery and the identification of mutations in genes known to cause disease. In the latter instance, WES identified mutations in known disease genes for 105 of 362 families studied (29%), thereby informing the impact of WES in the setting of the diagnostic odyssey. Our analysis of this dataset showed that these known disease genes were not identified prior to WES enrollment for two key reasons: genetic heterogeneity associated with a clinical diagnosis and atypical presentation of known, clinically recognized diseases. What is becoming increasingly clear is that WES will be paradigm altering for patients and families with rare genetic diseases.
                Bookmark

                Author and article information

                Journal
                J Med Genet
                J. Med. Genet
                jmedgenet
                jmg
                Journal of Medical Genetics
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0022-2593
                1468-6244
                November 2018
                26 July 2018
                : 55
                : 11
                : 721-728
                Affiliations
                [1 ] departmentGOSgene, Genetics and Genomic Medicine , UCL Great Ormond Street Institute of Child Health , London, UK
                [2 ] departmentDepartment of Clinical Genetics , North East Thames RegionalGenetics Service, Great Ormond Street Hospital for Children NHS Trust , London, UK
                [3 ] Congenica Ltd, Bioinnovation Data Centre, Wellcome Genome Campus , Cambridge, UK
                [4 ] departmentGenetics and Genomic Medicine , UCL Great Ormond Street Institute of Child Health , London, UK
                [5 ] departmentNE Thames Regional Genetics Laboratory , Great Ormond Street Hospital , London, UK
                [6 ] departmentRespiratory, Critical Care and Anaesthesia Unit , UCL Great Ormond Street Institute of Child Health and Great Ormond Street NHS Foundation Trust , London, UK
                Author notes
                [Correspondence to ] Dr Hywel J Williams, GOSgene, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK; hywel.williams@ 123456ucl.ac.uk
                Author information
                http://orcid.org/0000-0001-7758-0312
                Article
                jmedgenet-2018-105396
                10.1136/jmedgenet-2018-105396
                6252361
                30049826
                cf2f8bc7-ee28-406f-8ee7-fd4e9e84585a
                © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

                History
                : 09 April 2018
                : 22 May 2018
                : 10 June 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001921, Public Health Research Programme;
                Categories
                Diagnostics
                1506
                1304
                Original article
                Custom metadata
                unlocked

                Genetics
                whole genome sequencing,paediatric intensive care unit,rapid diagnosis,genomics,rare disease

                Comments

                Comment on this article